DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer

CompletedOBSERVATIONAL
Enrollment

182

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

June 30, 2010

Study Completion Date

October 31, 2016

Conditions
Breast Cancer
Interventions
GENETIC

DNA methylation analysis

laboratory analysis

GENETIC

microarray analysis

laboratory analysis

GENETIC

polymerase chain reaction

laboratory analysis

OTHER

laboratory biomarker analysis

laboratory analysis

Trial Locations (4)

55905

Mayo Clinic Cancer Center, Rochester

46202-5289

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis

21231-2410

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore

27599-7295

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00899548 - DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter